Insilico Medicine Unveils ISM9528, a Preclinical Non-Opioid Candidate Showing Superior Pain Relief to Morphine
On 23 July 2026, Insilico Medicine announced that its latest preclinical drug candidate, ISM9528, has outperformed both ...
Read story →Tag: Insilico Medicine
View all →
Insilico Medicine Projects First-Half 2026 Profit as AI-Driven Drug Program Reaches Phase III
Insilico Medicine (HKEX: 3696) has issued a profit alert for the first half of 2026, forecasting net income of $33.5 mil...
Read story →
Insilico Medicine and SK Biopharmaceuticals Announce $2.5 B Neuroimmune Drug Discovery Partnership
At the BIO 2026 International Convention in Cambridge, Mass., Insilico Medicine and SK Biopharmaceuticals unveiled a res...
Read story →